$AVGR News
Last published 2y ago
- 2y agoAVGRAvinger, Inc. (AVGR) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoAVGRAvinger to Announce Third Quarter 2024 Results on November 7, 2024ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / October 29, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 2y agoAVGRAvinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular InterventionACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / October 24, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 2y agoAVGRAvinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. PatentsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / September 18, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based systems for diagnosis
- 2y agoAVGRAvinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy DeviceACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / August 20, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 2y agoAVGRAvinger, Inc. (AVGR) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoAVGRAvinger Reports Second Quarter 2024 ResultsACCESS NewswireImplements Lower Operating Cost Profile, Readying OCT-Guided Coronary Device for IDE Submission REDWOOD CITY, CA / ACCESSWIRE / August 8, 2024 / Avinger, Inc. , a commercial-stage medical device company
- 2y agoAVGRAvinger Appoints Thomas P. Davis, MD, FACC as Chief Medical OfficerACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / August 5, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 2y agoAVGRAvinger to Announce Second Quarter 2024 Results on August 8, 2024ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / July 29, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 2y agoAVGRAvinger Announces Closing of up to $24 Million Public OfferingACCESS Newswire$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series WarrantsREDWOOD CITY, CA / ACCESSWIRE / June 17, 2024 / Avinger, Inc.
- 2y agoAVGRAvinger Announces Pricing of up to $24 Million Public OfferingACCESS Newswire$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon the exercise in full of clinical milestone-linked Series WarrantsREDWOOD CITY, CA / ACCESSWIRE / June 14, 2024 / Avinger, Inc.
- 2y agoAVGRAvinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral BusinessACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 5, 2024 / Avinger, Inc. , a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for
- 2y agoAVGRAvinger Announces Conversion of $11 Million of CRG Debt into Preferred EquityACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. , a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for
- 2y agoAVGRAvinger, Inc. (AVGR) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoAVGRAvinger Reports First Quarter 2024 ResultsACCESS NewswireAdvances New OCT-Guided Coronary Product Development REDWOOD CITY, CA / ACCESSWIRE / May 15, 2024 / Avinger, Inc. , a commercial-stage medical device company developing and marketing the first and only
- 2y agoAVGRAvinger to Announce First Quarter 2024 Results on May 15, 2024ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / May 7, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 2y agoAVGRAvinger, Inc. (AVGR) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoAVGRAvinger Reports Fourth Quarter and Full Year 2023 ResultsACCESS NewswireNew Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in AsiaREDWOOD CITY, CA / ACCESSWIRE / March 20, 2024 / Avinger, Inc.
- 2y agoAVGRAvinger to Announce Full Year 2023 Results on March 20, 2024ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / March 12, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 2y agoAVGRAvinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-TonbridgeACCESS NewswireInitial $7.5 Million Strategic InvestmentStrategic Partnership Opens Pathway to Access Greater China MarketStrengthened Balance Sheet and Three-Year Extension of Existing Debt TermsREDWOOD CITY, CA / ACCESSWIRE / March
- 3y agoAVGRAvinger Reports Third Quarter 2023 ResultsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / October 26, 2023 / Avinger, Inc. , a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for
- 3y agoAVGRAvinger to Announce Third Quarter 2023 Results on October 26ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / October 19, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRAvinger Raises $5.3 Million via At-The-Market FacilityACCESS NewswireStrengthens Balance Sheet in Support of Tigereye ST Launch and Coronary Product DevelopmentREDWOOD CITY, CA / ACCESSWIRE / September 27, 2023 / Avinger, Inc. , a commercial-stage medical device company
- 3y agoAVGRAvinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing DeviceACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / September 18, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRAvinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / August 24, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRAvinger Announces Conversion of 12% of CRG Term Debt into EquityACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / August 4, 2023 / Avinger, Inc. , a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for
- 3y agoAVGRAvinger Announces Presentations by Key Opinion Leaders at LINC 2023ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 20, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRAvinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual ConferenceACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 9, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRAvinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy SystemACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 7, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRAvinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing DeviceACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 5, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRAvinger Reports First Quarter 2023 ResultsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / May 10, 2023 / Avinger, Inc. , a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for
- 3y agoAVGRAvinger to Announce First Quarter 2023 Results on May 10ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / May 2, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRLeading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International SymposiumACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / April 28, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 3y agoAVGRAvinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing SystemACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / April 26, 2023 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and
- 4y agoAFIBAVGRHYPRNUVA+1BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory CouncilGlobeNewswireSAN JOSE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President
- 4y agoAVGRInterim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / September 1, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascu
- 4y agoAVGRAvinger Reports Second Quarter 2022 ResultsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / August 11, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascula
- 4y agoAVGRAvinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market Under Nasdaq RulesACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / August 8, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treat
- 4y agoAVGRAvinger to Announce Second Quarter 2022 Results on August 11ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / August 5, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Diseas
- 4y agoAVGRAvinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / August 4, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular
- 4y agoAVGRAvinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual ConferenceACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / June 6, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease
- 4y agoAVGRAvinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in GermanyACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease
- 4y agoAVGRAvinger Reports First Quarter 2022 ResultsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / May 10, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular d
- 4y agoAVGRAvinger to Announce First Quarter 2022 Results on May 10ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / April 29, 2022 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease
- 4y agoAVGRAvinger Announces Full Commercial Launch of Lightbox 3ACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular
- 4y agoAVGRAvinger Announces Issuance of Three New U.S. Patents in March 2022ACCESS Newswire16 New U.S. and International Patents Issued over Past Year REDWOOD CITY, CA / ACCESSWIRE / March 30, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, c
- 4y agoAVGRAvinger Regains Compliance with Nasdaq Listing RequirementsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / March 29, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Diseas
- 4y agoAVGRAvinger Reports Fourth Quarter and Year End 2021 ResultsACCESS NewswireREDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular
- 4y agoAVGRDPROENSVHOFV+1Thinking about buying stock in Draganfly, Enservco, Avinger, Hall of Fame Resort & Entertainment, or Tcr2 Therapeutics?PR NewswireNEW YORK, March 22, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DPRO, ENSV, AVGR, HOFV, and TCRR.
- 4y agoAVGREXNHYMCPSO+1Thinking about buying stock in Hycroft Mining, Excellon Resources, Avinger, Pearson, or Arcadia Biosciences?PR NewswireNEW YORK, March 15, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HYMC, EXN, AVGR, PSO, and RKDA. T